| Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines J Ansell, J Hirsh, E Hylek, A Jacobson, M Crowther, G Palareti Chest 133 (6), 160S-198S, 2008 | 7866* | 2008 |
| Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines C Kearon, EA Akl, AJ Comerota, P Prandoni, H Bounameaux, ... Chest 141 (2), e419S-e496S, 2012 | 4835 | 2012 |
| Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer AYY Lee, MN Levine, RI Baker, C Bowden, AK Kakkar, M Prins, ... New England journal of medicine 349 (2), 146-153, 2003 | 3165 | 2003 |
| The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia C Neunert, W Lim, M Crowther, A Cohen, L Solberg Jr, MA Crowther Blood, The Journal of the American Society of Hematology 117 (16), 4190-4207, 2011 | 2556 | 2011 |
| Executive SummaryExecutive SummaryAntithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines GH Guyatt, EA Akl, M Crowther, DD Gutterman, HJ Schuünemann CHEST Journal 141 (2_suppl), 7S-47S, 2012 | 2403* | 2012 |
| Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines W Ageno, AS Gallus, A Wittkowsky, M Crowther, EM Hylek, G Palareti Chest 141 (2), e44S-e88S, 2012 | 1971 | 2012 |
| Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice … A Holbrook, S Schulman, DM Witt, PO Vandvik, J Fish, MJ Kovacs, ... Chest 141 (2), e152S-e184S, 2012 | 1610 | 2012 |
| Systematic overview of warfarin and its drug and food interactions AM Holbrook, JA Pereira, R Labiris, H McDonald, JD Douketis, ... Archives of internal medicine 165 (10), 1095-1106, 2005 | 1559 | 2005 |
| Andexanet alfa for the reversal of factor Xa inhibitor activity DM Siegal, JT Curnutte, SJ Connolly, G Lu, PB Conley, BL Wiens, ... New England Journal of Medicine 373 (25), 2413-2424, 2015 | 1264 | 2015 |
| Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical … LA Linkins, AL Dans, LK Moores, R Bona, BL Davidson, S Schulman, ... Chest 141 (2), e495S-e530S, 2012 | 1165 | 2012 |
| Antiphospholipid syndrome G Ruiz-Irastorza, M Crowther, W Branch, MA Khamashta The Lancet 376 (9751), 1498-1509, 2010 | 1147 | 2010 |
| A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome MA Crowther, JS Ginsberg, J Julian, J Denburg, J Hirsh, J Douketis, ... New England Journal of Medicine 349 (12), 1133-1138, 2003 | 1121 | 2003 |
| Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism C Kearon, JS Ginsberg, MJ Kovacs, DR Anderson, P Wells, JA Julian, ... New England Journal of Medicine 349 (7), 631-639, 2003 | 1069 | 2003 |
| Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION ... Anesthesiology 120 (3), 564-578, 2014 | 982 | 2014 |
| Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines SM Bates, R Jaeschke, SM Stevens, S Goodacre, PS Wells, ... Chest 141 (2), e351S-e418S, 2012 | 972 | 2012 |
| Andexanet alfa for acute major bleeding associated with factor Xa inhibitors SJ Connolly, TJ Milling Jr, JW Eikelboom, CM Gibson, JT Curnutte, A Gold, ... New England Journal of Medicine 375 (12), 1131-1141, 2016 | 967 | 2016 |
| Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors SJ Connolly, M Crowther, JW Eikelboom, CM Gibson, JT Curnutte, ... New England Journal of Medicine 380 (14), 1326-1335, 2019 | 953 | 2019 |
| Acute kidney injury after cardiac surgery: focus on modifiable risk factors K Karkouti, DN Wijeysundera, TM Yau, JL Callum, DC Cheng, M Crowther, ... Circulation 119 (4), 495-502, 2009 | 933 | 2009 |
| Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura DM Arnold, F Dentali, MA Crowther, RM Meyer, RJ Cook, C Sigouin, ... Annals of internal medicine 146 (1), 25-33, 2007 | 786 | 2007 |
| Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial CH Lee, T Steiner, EO Petrof, M Smieja, D Roscoe, A Nematallah, ... Jama 315 (2), 142-149, 2016 | 764 | 2016 |
James DouketisProf of Medicine, David Braley Nancy Gordon Chair in Thromboembolic Disease, McMaster UniversityEmail verificata su mcmaster.ca